Pleomorphic epithelioid diffuse malignant pleural mesothelioma: A clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma

Journal of Thoracic Oncology

Volumn 6, Issue 5, 2011, Pages 896-904

  Kadota, Kyuichi ^a   Suzuki, Kei ^a   Sima, Camelia S ^a   Rusch, Valerie W ^a   Adusumilli, Prasad S ^a   Travis, William D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Epithelioid mesothelioma; Lymphatic invasion; Micropapillary; Pleomorphic; Survival

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EPITHELIOID DIFFUSE MALIGNANT PLEURAL MESOTHELIOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MICROPAPILLARY TUMOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEOMORPHIC TUMOR; PLEURA MESOTHELIOMA; PLEURECTOMY; PLEURECTOMY DECORTICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; SURVIVAL TIME; THORACOTOMY; TUBULOPAPILLARY TUMOR; TUMOR BIOPSY; TUMOR CLASSIFICATION; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 79955481828     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318211127a     Document Type: Article

References (47)

1. Allen TC. Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies. Arch Pathol Lab Med 2005;129:1415-1420. (Pubitemid 41587016)
2. Arrossi AV, Lin E, Rice D, et al. Histologic assessment and prognostic factors of malignant pleural mesothelioma treated with extrapleural pneumonectomy. Am J Clin Pathol 2008;130:754-764.
3. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 1999;68:1799-1804.
4. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative longterm survival in trimodality therapy of malignant pleural mesothelioma: results of 183 patients. J Thorac Cardiovasc Surg 1999;117:54-65. (Pubitemid 29022249)
5. Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007;2:957-965. (Pubitemid 47511601)
6. Travis W, Brambilla E, Muller-Hermelink H, et al. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus, and Heart. Lyon, France: IARC Press, 2004.
7. Curran D, Sahmoud T, Therasse P, et al. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol 1998;16:145-152. (Pubitemid 28041592)
8. Borasio P, Berruti A, Bille A, et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg 2008;33:307-313.
9. Ak G, Metintas S, Metintas M, et al. Prognostic factors according to the treatment schedule in malignant pleural mesothelioma. J Thorac Oncol 2009;4:1425-1430.
10. Okudela K, Woo T, Mitsui H, et al. Morphometric profiling of lung cancers. Its association with clinicopathologic, biologic, and molecular genetic features. Am J Surg Pathol 2010;34:243-255.
11. Motoi N, Szoke J, Riely GJ, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 2008;32:810-827.
12. Orvieto E, Maiorano E, Bottiglieri L, et al. Clinicopathologic characteristics of invasive lobular carcinoma of the breast. Cancer 2008;113: 1511-1520.
13. Reeves GK, Pirie K, Green J, et al. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer 2009;100:538-544.
14. Chiaravalli AM, Klersy C, Tava F, et al. Lower- and higher-grade subtypes of diffuse gastric cancer. Hum Pathol 2009;40:1591-1599.
15. Solcia E, Klersy C, Mastracci L, et al. A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch 2009;455:197-211.
16. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestosassociated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the pneumoconiosis committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 1982;106:544-596.
17. Battifora H, McCaughey EWT. Tumours of the Serosal Membranes. Washington, DC: Armed Forces Institute of Pathology, 1995.
18. Travis W, Colby T, Corrin B, et al. World Health Organization Classification of Tumours. Histological Subtyping of Lung and Pleural Tumours. Berlin: Springer, 1999.
19. Greene F, Page D, Fleming I, et al. AJCC Cancer Staging Manual, 6th Ed. New York: Springer, 2002.
20. Tomashefski J, Cagle P, Farver F, et al. Dail and Hammar's Pulmonary Pathology, 3rd Ed. New York: Springer, 2008.
21. Mogi A, Nabeshima K, Hamasaki M, et al. Pleural malignant mesothelioma with invasive micropapillary component and its association with pulmonary metastasis. Pathol Int 2009;59:874-879.
22. Shia J, Qin J, Erlandson R, et al. Malignant mesothelioma with a pronounced myxoid stroma: a clinical and pathological evaluation of 19 cases. Virchows Arch 2005;447:828-834. (Pubitemid 41728871)
23. Heller G, Venkatraman ES. A nonparametric test to compare survival distributions with covariate adjustment. J R Statist Soc B 2004;66:719-733. (Pubitemid 39015909)
24. Corson JM. Pathology of mesothelioma. Thorac Surg Clin 2004;14:447-460. (Pubitemid 39314478)
25. Mochizuki T, Ishii G, Nagai K, et al. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases. Am J Surg Pathol 2008;32:1727-1735.
26. Galateau-Salle F, Le Stang N, Astoul P, et al. Malignant mesothelioma of the pleura with pleomorphic features: a series of 44 cases. Modern Pathol 2010;23(Supp):402A.
27. Johansson L, Lindén C-J. Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas. Chest 1996;109:109-114. (Pubitemid 26017604)
28. Cerruto CA, Brun EA, Chang D, et al. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med 2006;130:1654-1661. (Pubitemid 44683793)
29. Nassar H, Wallis T, Andea A, et al. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 2001;14:836-841. (Pubitemid 32889240)
30. Pettinato G, Manivel CJ, Panico L, et al. Invasive micropapillary carcinoma of the breast. Am J Clin Pathol 2004;121:857-866.
31. Miyoshi T, Satoh Y, Okumura S, et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am J Surg Pathol 2003;27:101-109. (Pubitemid 36014903)
32. Johansson SL, Borghede G, Holmang S. Micropapillary bladder carcinoma: a clinicopathological study of 20 cases. J Urol 1999;161:1798-1802. (Pubitemid 29420734)
33. Haupt B, Ro JY, Schwartz MR, et al. Colorectal adenocarcinoma with micropapillary pattern and its association with lymph node metastasis. Mod Pathol 2007;20:729-733. (Pubitemid 46933443)
34. Sakamoto K, Watanabe M, Cruz CDL, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology 2005;47:479-484. (Pubitemid 41626725)
35. Nagao T, Gaffey TA, Visscher DW, et al. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Am J Surg Pathol 2004;28:319-326. (Pubitemid 38269565)
36. Mark EJ, Shin D-H. Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival. Virchows Arch 1993;422:445-451. (Pubitemid 23223659)
37. Edwards JG, Stewart DJ, Martin-Ucar A, et al. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma. J Thorac Cardiovasc Surg 2006;131: 981-987.
38. de Perrot M, Uy K, Anraku M, et al. Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2007;133:111-116. (Pubitemid 46014196)
39. Flores RM, Routledge T, Seshan VE, et al. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer Staging System. J Thorac Cardiovasc Surg 2008;136:605-610.
40. Mineo TC, Ambrogi V, Pompeo E, et al. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma. Ann Thorac Surg 2008;85:1740-1746. (Pubitemid 351608195)
41. Richards WG, Godleski JJ, Yeap BY, et al. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer 2010;116:1510-1517.
42. Nowak AK, Francis RJ, Phillips MJ, et al. A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clin Cancer Res 2010;16:2409-2417.
43. Lopez-Rios F, Chuai S, Flores R, et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/ CDKN2A deletion as prognostic Factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 2006;66:2970-2979.
44. Gordon GJ, Jensen RV, Hsiao LL, et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 2003;95:598-605. (Pubitemid 36553506)
45. Gordon GJ, Rockwell GN, Godfrey PA, et al. Validation of genomicsbased prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 2005;11:4406-4414. (Pubitemid 40825631)
46. Pass HI, Liu Z, Wali A, et al. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin Cancer Res 2004;10: 849-859. (Pubitemid 38198883)
47. Pass HI, Goparaju C, Ivanov S, et al. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res 2010;70: 1916-1924.